Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Res Vet Sci ; 98: 142-4, 2015 Feb.
Article in English | MEDLINE | ID: mdl-25435342

ABSTRACT

The antiviral effect of polysaccharides has been known for many years. Carrageenans are considered a good alternative for the prevention of a wide range of diseases, mainly caused by enveloped viruses. The advantages lie on their high availability, low cost and low induction of resistance. The aim of this study was to evaluate the sensitivity of two viral pathogens of veterinary interest to the presence of lambda-carrageenan. This is the first report of a lambda-carrageenan having antiviral activity against animal viruses belonging to the Alphaherpesvirinae subfamily, BoHV-1 (bovine herpesvirus type 1) strain Cooper and SuHV-1 (suid herpesvirus type 1) strain Bartha. Lambda-carrageenan was able to reduce infectivity of both viruses with a more pronounced effect against BoHV-1. These results proved, as previously shown for human herpes virus type 1, that these compounds could be used as potential antiviral agents in the veterinary field.


Subject(s)
Antiviral Agents/pharmacology , Carrageenan/pharmacology , Herpesvirus 1, Bovine/drug effects , Herpesvirus 1, Suid/drug effects , Rhodophyta/chemistry , Animals , Dogs , Madin Darby Canine Kidney Cells
2.
Arch Virol ; 159(11): 2843-51, 2014 Nov.
Article in English | MEDLINE | ID: mdl-25000902

ABSTRACT

Caenorhabditis elegans is a worm that has been extensively studied, and it is today an accepted model in many different biological fields. C. elegans is cheap to maintain, it is transparent, allowing easy localization studies, and it develops from egg to adult in around 4 days. Many mutants, available to the scientific community, have been developed. This has facilitated the study of the role of particular genes in many cellular pathways, which are highly conserved when compared with higher eukaryotes. This review describes the advantages of C. elegans as a laboratory model and the known mechanisms utilized by this worm to fight pathogens. In particular, we describe the strong C. elegans RNAi machinery, which plays an important role in the antiviral response. This has been shown in vitro (C. elegans cell cultures) as well as in vivo (RNAi-deficient strains) utilizing recently described viruses that have the worm as a host. Infections with mammalian viruses have also been achieved using chemical treatment. The role of viral genes involved in pathogenesis has been addressed by evaluating the phenotypes of transgenic strains of C. elegans expressing those genes. Very simple approaches such as feeding the worm with bacteria transformed with viral genes have also been utilized. The advantages and limitations of different approaches are discussed.


Subject(s)
Caenorhabditis elegans/virology , Disease Models, Animal , Virus Diseases/virology , Virus Physiological Phenomena , Animals , Caenorhabditis elegans/genetics , Caenorhabditis elegans/metabolism , Host-Pathogen Interactions , Humans , Virus Diseases/genetics , Virus Diseases/metabolism , Viruses/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...